Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive D-cycloserine in rTMS for Depression
NCT03937596Phase 2Completed
- Sponsor
- University of Calgary
- Start
- Dec 2019
- Primary completion
- Dec 2020
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-cycloserine in major depressive disorder (MDD), sponsored by University of Calgary. Started Dec 2019; status: completed.
02
Drugs
d-cycloserine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03937596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03937596.